Literature DB >> 12518293

Ketamine and fMRI BOLD signal: distinguishing between effects mediated by change in blood flow versus change in cognitive state.

Kathryn M Abel1, Matthew P G Allin, Katarzyna Kucharska-Pietura, Chris Andrew, Steve Williams, Anthony S David, Mary L Phillips.   

Abstract

No human fMRI studies have examined ketamine effects on the BOLD signal change associated with cognitive task performance. We wished to distinguish between effects on 1) cerebral blood flow, with resultant change in BOLD signal; and 2) cognition and neural mechanisms underlying BOLD signal change associated with task performance. Eight right-handed men (mean age 28.75 years) received ketamine or saline i.v. in a randomized, double-blind manner (bolus 0.23 mg/kg; 0.5 mg/kg over 45 min to a maximum 1 hr). Subjects viewed 10 alternating 30-sec blocks of faces with neutral expressions and a fixation cross and discriminated gender of faces. Gradient echo echoplanar images were acquired on a GE Signa 1.5 T Neurovascular system. One hundred T2-weighted images depicting BOLD contrast were acquired over 5 min (for each task) at each of 14 near-axial noncontiguous 7-mm thick planes. Ketamine significantly increased dissociative phenomena and negative symptoms, but did not affect performance of the gender discrimination task. Significant BOLD signal change was demonstrated predominantly in occipitotemporal cortex with both ketamine and placebo. Only two clusters in middle occipital gyrus (BA 18) and precentral gyrus (BA 4) showed significantly decreased BOLD signal change during ketamine compared to placebo. BOLD signal change was not significantly greater in any region during ketamine. Our findings demonstrate subtle rather than major differences between the effects of ketamine and placebo upon the BOLD signal change during perception of face-non face contrast. We suggest that they represent task-dependent effects of the drug/placebo, rather than task-independent effects of the drug per se, and indicate that the effects of ketamine on cerebral blood flow are predominantly focal and task-dependent, rather than global and task-independent. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12518293      PMCID: PMC6871893          DOI: 10.1002/hbm.10064

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  37 in total

1.  Quality control for functional magnetic resonance imaging using automated data analysis and Shewhart charting.

Authors:  A Simmons; E Moore; S C Williams
Journal:  Magn Reson Med       Date:  1999-06       Impact factor: 4.668

2.  Regulation of cerebral microvessels by glutamatergic mechanisms.

Authors:  A Fergus; K S Lee
Journal:  Brain Res       Date:  1997-04-18       Impact factor: 3.252

3.  Brain magnetic resonance imaging with contrast dependent on blood oxygenation.

Authors:  S Ogawa; T M Lee; A R Kay; D W Tank
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI.

Authors:  E T Bullmore; M J Brammer; S Rabe-Hesketh; V A Curtis; R G Morris; S C Williams; T Sharma; P K McGuire
Journal:  Hum Brain Mapp       Date:  1999       Impact factor: 5.038

5.  Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS).

Authors:  J D Bremner; J H Krystal; F W Putnam; S M Southwick; C Marmar; D S Charney; C M Mazure
Journal:  J Trauma Stress       Date:  1998-01

6.  Cerebral cortical neurons with activity linked to central neurogenic spontaneous and evoked elevations in cerebral blood flow.

Authors:  E V Golanov; D J Reis
Journal:  Neurosci Lett       Date:  1996-05-10       Impact factor: 3.046

7.  Face encoding and recognition in the human brain.

Authors:  J V Haxby; L G Ungerleider; B Horwitz; J M Maisog; S I Rapoport; C L Grady
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

8.  Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers.

Authors:  A Breier; A K Malhotra; D A Pinals; N I Weisenfeld; D Pickar
Journal:  Am J Psychiatry       Date:  1997-06       Impact factor: 18.112

9.  Absence of N-methyl-D-aspartate receptors on ovine cerebral microvessels.

Authors:  P M Beart; K A Sheehan; D T Manallack
Journal:  J Cereb Blood Flow Metab       Date:  1988-12       Impact factor: 6.200

10.  Effects of inhibitory and excitatory amino acid neurotransmitters on isolated cerebral parenchymal arterioles.

Authors:  M Takayasu; R G Dacey
Journal:  Brain Res       Date:  1989-03-20       Impact factor: 3.252

View more
  17 in total

Review 1.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

Review 2.  Ketamine for treatment-resistant unipolar depression: current evidence.

Authors:  Sanjay J Mathew; Asim Shah; Kyle Lapidus; Crystal Clark; Noor Jarun; Britta Ostermeyer; James W Murrough
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

3.  Ketamine administration reduces amygdalo-hippocampal reactivity to emotional stimulation.

Authors:  Milan Scheidegger; Anke Henning; Martin Walter; Mick Lehmann; Rainer Kraehenmann; Heinz Boeker; Erich Seifritz; Simone Grimm
Journal:  Hum Brain Mapp       Date:  2016-02-25       Impact factor: 5.038

4.  Selective potentiation of the metabotropic glutamate receptor subtype 2 blocks phencyclidine-induced hyperlocomotion and brain activation.

Authors:  E A Hackler; N E Byun; C K Jones; J M Williams; R Baheza; S Sengupta; M D Grier; M Avison; P J Conn; J C Gore
Journal:  Neuroscience       Date:  2010-03-27       Impact factor: 3.590

5.  Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency.

Authors:  Arne Nagels; André Kirner-Veselinovic; Richard Wiese; Frieder M Paulus; Tilo Kircher; Sören Krach
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-12-22       Impact factor: 5.270

Review 6.  Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature.

Authors:  Dawn F Ionescu; Julia M Felicione; Aishwarya Gosai; Cristina Cusin; Philip Shin; Benjamin G Shapero; Thilo Deckersbach
Journal:  Harv Rev Psychiatry       Date:  2018 Nov/Dec       Impact factor: 3.732

Review 7.  Does neuroimaging research examining the pathophysiology of posttraumatic stress disorder require medication-free patients?

Authors:  Ruth A Lanius; Chris R Brewin; J Douglas Bremner; Judith K Daniels; Matthew J Friedman; Israel Liberzon; Alexander McFarlane; Paula P Schnurr; Lisa Shin; Murray Stein; Eric Vermetten
Journal:  J Psychiatry Neurosci       Date:  2010-03       Impact factor: 6.186

8.  The effects of the glutamate antagonist memantine on brain activation to an auditory perception task.

Authors:  Heidi van Wageningen; Hugo A Jørgensen; Karsten Specht; Tom Eichele; Kenneth Hugdahl
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

9.  Ketamine-Induced Hallucinations.

Authors:  Albert R Powers; Mark G Gancsos; Emily S Finn; Peter T Morgan; Philip R Corlett
Journal:  Psychopathology       Date:  2015-09-12       Impact factor: 1.944

Review 10.  Comorbidity implications in brain disease: neuronal substrates of symptom profiles.

Authors:  Tomas Palomo; Richard J Beninger; Richard M Kostrzewa; Trevor Archer
Journal:  Neurotox Res       Date:  2007-07       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.